Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Moxidectin/Albendazole vs Ivermectin/Albendazole in Trichuriasis
NCT04700423Phase 3Completed
- Start
- Mar 2021
- Primary completion
- Aug 2021
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
A Phase 3 trial of moxidectin in trichuriasis, ascariasis, hookworm infection. Started Mar 2021; status: completed.
02
Drugs
moxidectin
03
Conditions
trichuriasisascariasishookworm infection
Beyond the preview
Go deeper on NCT04700423.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04700423.